Feedback / Questions
LiProSal (lithium/proline/salicylate) - Alzamend Neuro
https://www.businesswire.com/news/home/20220428005596/en/BitNile-Holdings-Announces-Additional-Investment-in-Alzamend-From-Completion-of-Phase-1-First-in-Human-Clinical-Trial-for-AL001-Treatment-of-Dementia-Related-to-Alzheimer%E2%80%99s
Apr 28, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next